Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vladimir Beljanski

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Current Opinion in Virology|August 23, 2012
The use of oncolytic viruses to overcome lung cancer drug resistanceVladimir Beljanski, John Hiscott
Non-Coding RNA Research|January 28, 2022
Exosomal RNAs in diagnosis and therapiesPranay Narang, Morish Shah, Vladimir Beljanski
Biological Chemistry|June 13, 2015
The intersection between viral oncolysis, drug resistance, and autophagyVladimir Beljanski, Cindy Chiang, John Hiscott
Non-Coding RNA|November 22, 2022
Exosome RNA Sequencing as a Tool in the Search for Cancer BiomarkersMarina Elkommos-Zakhary, Neeraja Rajesh, Vladimir Beljanski
The Journal of Pharmacology and Experimental Therapeutics|February 25, 2010
A novel sphingosine kinase inhibitor induces autophagy in tumor cellsVladimir Beljanski, Christian Knaak, Charles D Smith
Cytotherapy|March 17, 2019
Pleiotropic roles of autophagy in stem cell-based therapiesVladimir Beljanski, Karl-Henrik Grinnemo, Cecilia Österholm
Molecular Pharmacology|May 25, 2004
DNA damage-processing pathways involved in the eukaryotic cellular response to anticancer DNA cross-linking drugsVladimir Beljanski, Luigi G Marzilli, Paul W Doetsch
Cancer Biology & Therapy|January 25, 2011
Antitumor activity of sphingosine kinase 2 inhibitor ABC294640 and sorafenib in hepatocellular carcinoma xenograftsVladimir Beljanski, Clayton S Lewis, Charles D Smith
Investigational New Drugs|May 18, 2010
Combined anticancer effects of sphingosine kinase inhibitors and sorafenibVladimir Beljanski, Christian Knaak, Yan Zhuang, et al.
Stem Cell Research & Therapy|November 19, 2020
Differences and similarities between cancer and somatic stem cells: therapeutic implicationsFiorella Rossi, Hunter Noren, Richard Jove, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Current Opinion in Virology|August 23, 2012
The use of oncolytic viruses to overcome lung cancer drug resistanceVladimir Beljanski, John Hiscott
Non-Coding RNA Research|January 28, 2022
Exosomal RNAs in diagnosis and therapiesPranay Narang, Morish Shah, Vladimir Beljanski
Biological Chemistry|June 13, 2015
The intersection between viral oncolysis, drug resistance, and autophagyVladimir Beljanski, Cindy Chiang, John Hiscott
Non-Coding RNA|November 22, 2022
Exosome RNA Sequencing as a Tool in the Search for Cancer BiomarkersMarina Elkommos-Zakhary, Neeraja Rajesh, Vladimir Beljanski
The Journal of Pharmacology and Experimental Therapeutics|February 25, 2010
A novel sphingosine kinase inhibitor induces autophagy in tumor cellsVladimir Beljanski, Christian Knaak, Charles D Smith
Cytotherapy|March 17, 2019
Pleiotropic roles of autophagy in stem cell-based therapiesVladimir Beljanski, Karl-Henrik Grinnemo, Cecilia Österholm
Molecular Pharmacology|May 25, 2004
DNA damage-processing pathways involved in the eukaryotic cellular response to anticancer DNA cross-linking drugsVladimir Beljanski, Luigi G Marzilli, Paul W Doetsch
Cancer Biology & Therapy|January 25, 2011
Antitumor activity of sphingosine kinase 2 inhibitor ABC294640 and sorafenib in hepatocellular carcinoma xenograftsVladimir Beljanski, Clayton S Lewis, Charles D Smith
Investigational New Drugs|May 18, 2010
Combined anticancer effects of sphingosine kinase inhibitors and sorafenibVladimir Beljanski, Christian Knaak, Yan Zhuang, et al.
Stem Cell Research & Therapy|November 19, 2020
Differences and similarities between cancer and somatic stem cells: therapeutic implicationsFiorella Rossi, Hunter Noren, Richard Jove, et al.
Pageof 4